Researchers are currently busy finding potential therapies to treat vitiligo, a disease that causes the loss of skin colour in blotches. While it can be treated, they now want to trial oral systemic pharmacological treatments specifically to treat non-segmental vitiligo and are seeking candidates who would like to avail themselves for the study. Lester Kiewit speaks to Dr Suretha Kannenberg, dermatologist and principal investigator for the study.